9 July 2020 - Medicines regulatory authorities from around the world have published a report today highlighting the outcomes ...
7 July 2020 - Value in Health announced today the publication of results of an ISPOR systematic review and analysis ...
1 July 2020 - EMA has endorsed a joint statement on prioritisation of COVID-19 clinical trials published by the International ...
30 June 2020 - Medicines Australia welcomes the announcement from the Minister for Health, the Hon Greg Hunt MP, during ...
24 June 2020 - Under the umbrella of the International Coalition of Medicines Regulatory Authorities, international regulators discussed COVID-19 vaccine ...
18 June 2020 - For years, the pharmaceutical industry has maintained that the costs to develop medicines accounts for rising ...
17 June 2020 - A low-cost, widely used anti-inflammatory drug has improved survival in patients with COVID-19, scientists say, the ...
4 June 2020 - The Lancet, one of the world’s top medical journals, on Thursday retracted an influential study that ...
4 June 2020 - The World Health Organization will resume its trial of hydroxychloroquine for potential use against the coronavirus, its ...
3 June 2020 - The first carefully controlled trial of hydroxychloroquine given to people exposed to the coronavirus did not show ...
1 June 2020 - In a response to officials at Germany’s IQWiG and the Cochrane Collaboration, EMA Executive Director Guido ...
28 May 2020 - Australian researchers have suspended patient recruitment in a major clinical trial of the controversial anti-malaria drug ...
26 May 2020 - The World Health Organisation has announced a temporary pause on a clinical trial arm testing hydroxycholoroquine ...
26 May 2020 - For observational studies of real world data in COVID-19, EMA calls for transparency for protocols and results, ...
26 May 2020 - Australian researchers are pressing ahead with administering the controversial antimalarial drug hydroxychloroquine in at least one ...